Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...

Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

Biogen and Eisai have spent much of Leqembi’s launch convincing physicians and patients that it’s safe to treat Alzheimer’s ...

Scientists believe they have found a major link between Alzheimer's disease and a dieting hack, which is followed by millions ...

Intermittent fasting may be the key to slowing or even reversing the signs of Alzheimer's disease, a new study suggests.

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

A new biomarker test identifies very early stages of tau tangle formation, up to a decade before any tau clumps can show up ...

PITTSBURGH (KDKA) — A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was created to detect the disease in the brain earlier.

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.